The company will use the new financing to support the in-hospital launch of the FlowSense shunt monitor, a thermal sensor that monitors shunt function in people with hydrocephalus. Additionally, the funding will be used to accelerate an at-home version of FlowSense, according to a Feb. 16 Rhaeos news release.
The Steele Foundation for Help led the financing round, bringing the company’s total raised to more than $18 million.
In 2021, the company was part of Los Angeles-based Cedars-Sinai’s innovation accelerator for medtech companies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
